Delos Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History

Delos Wealth Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,000	Closed	-$9.31K	–	358
2023 Q4	$9.31K	Hold	1,000	–	–	0.01%	101
2023 Q3	$7.9K	Hold	1,000	–	–	0.01%	146
2023 Q2	$8.13K	Hold	1,000	–	–	0.01%	145
2023 Q1	$8.57K	Hold	1,000	–	–	0.01%	136
2022 Q4	$9.26K	Hold	1,000	–	–	0.01%	139
2022 Q3	$10K	Hold	1,000	–	–	0.01%	134
2022 Q2	$10K	Hold	1,000	–	–	0.01%	138
2022 Q1	$12K	Hold	1,000	–	–	0.01%	153
2021 Q4	$17K	Hold	1,000	–	–	0.02%	140
2021 Q3	$18K	Hold	1,000	–	–	0.02%	73
2021 Q2	$23K	Buy	+1,000	New	+$14.8K	0.03%	65

Other funds holding AVXL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rafferty Asset Management

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return